Extreme Hypofractionation versus Conventionally Fractionated Radiotherapy for Intermediate Risk Prostate Cancer: Early Toxicity Results from the Scandinavian Randomized Phase III Trial “HYPO-RT-PC”-Reference-Cited by-同舟云学术

Extreme Hypofractionation versus Conventionally Fractionated Radiotherapy for Intermediate Risk Prostate Cancer: Early Toxicity Results from the Scandinavian Randomized Phase III Trial “HYPO-RT-PC”

Published:2016-12 Issue:5 Volume:96 Page:938-939
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Widmark A.,Gunnlaugsson A.,Beckman L.,Thellenberg-Karlsson C.,Hoyer M.,Lagerlund M.,Fransson P.,Kindblom J.,Ginman C.,Johansson B.,Seke M.,Björnlinger K.,Kjellén E.,Franzen L.,Nilsson P.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate Cancer;Tata Memorial Centre Textbook of Oncology;2024

2. Urethra Sparing With Target Motion Mitigation in Dose-Escalated Extreme Hypofractionated Prostate Cancer Radiotherapy: 7-Year Results From a Phase II Study;Frontiers in Oncology;2022-03-29

3. Can the Adoption of Hypofractionation Guidelines Expand Global Radiotherapy Access? An Analysis for Breast and Prostate Radiotherapy;JCO Global Oncology;2020-11

4. Radiotherapie bij primaire prostaatkanker: als minder meer wordt;Tijdschrift voor Geneeskunde;2020-11-01

5. Phase II prospective trial “Give Me Five” short-term high precision radiotherapy for early prostate cancer with simultaneous boost to the dominant intraprostatic lesion: the impact of toxicity on quality of life (AIRC IG-13218);Medical Oncology;2020-07-28